2Dedrick RL.Theoretical and experimental bases of intrperitoneal chemotherapy. Semin Oncol, 1985,12 (suppl4) : 1-5.
3Markman M, Reichaman B, hakes T, et al. Intraperitoneal chemotherapy in the management of ovarian cancer.Yale I Biol Med, 1993,71 : 1565-1571.
4Alberts DS, Liu Py, Hannigan EV, et al. Intraperitoneal cisplatin plus in trarenous cisplatin plus intravenous cyclophvs phamide for stage 3 ovarianeancer. N Engl J Med, 1996,335:1 950-1 955.
5Markman M, Bundy BN,Alberts DS,et al. Phase3 trial of standard-dose intravenous cisplatin plus paclitaxel versus moderately high-dose carboplatin followed by intravenous paclitaxel and intraperitoneal cisplat in small-volume stage 3 ovarian carcinoma: an intergroup study of the Gynecologic Oncology Group, Southwestern Oncology Group, and Eastern Cooperative Oncology Group. J Clin Oncol,2001,19: 1001-1007.
6Rothenberg ML, Liu PY, Braly PS, et al. Combined intraperirtoneal and intravenous chemotherapy for woman with optimally debulked ovarian cancer: resuits from an intergroup phase2 tfial.J Clin Oncol,2003,21 : 1313-1319.
7Fujiwara K, Markman M, Morgan M, et al. Intraperitoneal carboplatin-based chemotherapy for pithelial ovarian cancer. Gynecol Oncol, 2005,97 : 10-15.
8Bos AM, De Vos FY, de Vries EG, et al. A phase Ⅰ study of intraperitoneal topotecan in combination with intravenous carboplatin and paclitaxel in advanced ovarian cancer. Eur J Cancer,2005,41:539-548.
9De Bree E, Rernanos J, Michalakis J, et al. Intraperitoneal heperthermic chemotherapy with docetaxel as sencond-line treatment for peritoneal carcinomalosis of gynaecological origin. Antican Res, 2003,23 : 3019-3027.
10Ryu KS, Kim JH, Kohs, et al. Effects of intraperitoneal hyperthemic chemo therapy in ovarian cancer. Gynecol-Oncol,2004,94: 325-332.
6Alberts DS, Hannigan EV,Liu PY,et al. Randomized trial of adjuvant intrap- eritoneal alpha-interferon in stage Ⅲ ovarian cancer patients who have no evidence of disease after primary surgery and chemotherapy: an intergroup study. Gynecol Oncol,2006, 100:133-138.
7Salzberg M, Thurlimann B, Bonnefois H, et al. current concepts of treatment strategies in advanced or recurrent ovarian cancer. Oncology, 2005,68: 293- 298.
8Choan C, Quon M, Gallant V, et al. Effective palliative radiotherapy for symp- tomatic recurrent or residual ovarian cancer. Gynccol Oncol, 2006, 102: 204- 209.
